financetom
Business
financetom
/
Business
/
BRIEF-Seven & I Holdings Co Ltd - 7&I Board Has Unanimously Concluded, Based On The Unanimous Recommendation Of The Special Committee, That The Proposal Is Not In The Best Interest Of 7&I Shareholders
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Seven & I Holdings Co Ltd - 7&I Board Has Unanimously Concluded, Based On The Unanimous Recommendation Of The Special Committee, That The Proposal Is Not In The Best Interest Of 7&I Shareholders
Sep 5, 2024 5:43 PM

Sept 6 (Reuters) - Seven & i Holdings Co Ltd ( SVNDF ):

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - SEVEN AND I HOLDINGS' ( SVNDF ) BOARD RESPONDS TO

NON-BINDING

PROPOSAL FROM ALIMENTATION COUCHE-TARD INC

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - WE BELIEVE THAT PROPOSAL DOES NOT ADEQUATELY

ACKNOWLEDGE MULTIPLE AND SIGNIFICANT CHALLENGES SUCH A TRANSACTION WOULD FACE

FROM U.S. COMPETITION LAW ENFORCEMENT AGENCIES IN CURRENT REGULATORY ENVIRONMENT

* SEVEN & I HOLDINGS CO LTD SAYS COUCHE-TARD OFFERED TO BUY SEVEN & I

SHARES AT

$14.86 PER SHARE IN CASH

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - OPEN TO SINCERELY CONSIDER ANY PROPOSAL THAT

IS IN

THE BEST INTERESTS OF 7&I SHAREHOLDERS AND OTHER STAKEHOLDERS

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - HOWEVER, WE WILL RESIST ANY PROPOSAL THAT

DEPRIVES

OUR SHAREHOLDERS OF THE COMPANY'S INTRINSIC VALUE OR THAT FAILS TO SPECIFICALLY

ADDRESS VERY REAL REGULATORY CONCERNS.

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - 7&I BOARD HAS UNANIMOUSLY CONCLUDED, BASED ON

THE

UNANIMOUS RECOMMENDATION OF THE SPECIAL COMMITTEE, THAT THE PROPOSAL IS NOT IN

THE BEST INTEREST OF 7&I SHAREHOLDERS AND OTHER STAKEHOLDERS

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - WE ARE OPEN TO ENGAGING IN SINCERE DISCUSSIONS

SHOULD YOU PUT FORTH A PROPOSAL THAT FULLY RECOGNIZES OUR STANDALONE INTRINSIC

VALUE AND ADDRESSES OUR CONCERNS REGARDING CERTAINTY OF CLOSING IN THE CURRENT

REGULATORY ENVIRONMENT

* SEVEN & I HOLDINGS CO LTD ( SVNDF ) - EVEN IF COUCHE-TARD WAS ABLE TO IMPROVE VALUE

ELEMENT OF ITS PROPOSAL VERY SIGNIFICANTLY, THE PROPOSAL DOES NOT ADEQUATELY

ACKNOWLEDGE MULTIPLE AND SIGNIFICANT CHALLENGES

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Alpha Group International plc
Form 8.3 - Alpha Group International plc
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - PRS REIT plc
Form 8.3 - PRS REIT plc
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - International Personal Finance plc
Form 8.3 - International Personal Finance plc
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio
Oct 21, 2025
LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- GLD Partners, LP, with a growing footprint of investments in life sciences, healthcare, and biotech, today announced the successful acquisition of select assets from Seelos Therapeutics, Inc. through the Chapter 11 bankruptcy process. Following its acquisition of Seelos’ senior secured debt, GLD served as the stalking horse bidder in the U.S. Bankruptcy Court in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved